ÆüËÜÇÀ·Ý²½³Ø²ñ 2025ǯÅÙÂç²ñ¥×¥í¥°¥é¥à¸¡º÷

¥×¥í¥°¥é¥à½¸PDF Âç²ñ¥È¥Ã¥×¥Ú¡¼¥¸¤ËÌá¤ë
¿ä¾©¥Ö¥é¥¦¥¶¡§Chrome¡¢FireFox¡¢Edge¡¢Safari
(Internet Explorer¤Ç¤ÏÀµ¤·¤¯É½¼¨¤µ¤ì¤Ê¤¤¾ì¹ç¤¬¤¢¤ê¤Þ¤¹)
Recommended browsers: Chrome, FireFox, Edge, Safari
(May not display correctly in Internet Explorer)

»á̾:YoshieYAMANA ¤Î¸¡º÷·ë²Ì

1 - 1  / 1 <<< 1 >>>

1 - 1  / 1
<<< 1 >>>
3D093
2025/03/06 13:15
¥Ý¥¹¥¿¡¼¡¦Å¸¼¨²ñ¾ì
Æý»À¶ÝLP22A-3¤Î¥¢¥ì¥ë¥®¡¼À­±ê¾ÉÍÞÀ©¸ú²Ì
The oral administration of Lactiplantibacillus plantarum (LP22A-3) suppresses an allergic inflammation
³¤Ìî ¶Á±û²Â1¡¢¶áß· ̤Êâ1¡¢úɸ¶ ¹ÀÀ¿2¡¢ÅÄÀî ³Ù2¡¢»³Ì¾ Èþ¹¾2¡¢¿åÌî ²í»Ë3¡¢¡ûÌ« ·ò°ìϺ1
Kyoka UNNO1, Miho CHIKAZAWA1, Hiroshige KUWAHARA2, Takashi TAGAWA2, Yoshie YAMANA2, Masashi MIZUNO3, ¡ûKenichiro MINATO1
1̾¾ëÂçÇÀ¡¢2´ÝÁ±À½ÌôÁí¹ç¸¦µæ½ê¡¢3ÂçºåÀÄ»³Âç·ò¹¯²Ê³Ø
1Meijo Univ., 2Maruzen Pharmaceuticals Co., 3Osaka Aoyama Univ.
1 - 1  / 1 <<< 1 >>>

1 - 1  / 1
<<< 1 >>>